News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
167 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39122)
2019 (51337)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42567)
2024 (37443)
2025 (33092)
2026 (4321)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4506)
June (2887)
July (2192)
August (2499)
September (2721)
October (3233)
November (3383)
December (2291)
Day
2 (25)
3 (171)
4 (157)
5 (194)
6 (65)
9 (167)
10 (111)
11 (154)
12 (151)
13 (101)
16 (193)
17 (121)
18 (134)
19 (126)
20 (76)
23 (123)
24 (139)
25 (89)
26 (95)
27 (153)
30 (176)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
16
17
18
19
20
23
24
25
26
27
30
Press Releases
Perioperative Ivonescimab (PD-1/VEGF) for NSCLC Demonstrated Clinically Significant Phase II Results, Presented in Oral Session at WCLC 2024
September 9, 2024
·
5 min read
Press Releases
Ultimovacs Announces Updated Data Analysis on UV1 Phase II NIPU Trial in Mesothelioma at ESMO 2024
September 9, 2024
·
6 min read
Press Releases
Roche advances AI-driven cancer diagnostics by expanding its digital pathology open environment
September 9, 2024
·
4 min read
Press Releases
Hemogenyx Pharmaceuticals PLC - FLT3 Assay Ready for Phase I Trials at MD Anderson
September 9, 2024
·
4 min read
Press Releases
Anocca Presents Data at ESMO Congress on Preclinical Development of its TCR-T Cell Therapies for Cancer
September 9, 2024
·
2 min read
Press Releases
Immunovant Provides Update on Graves’ Disease Development Program
September 9, 2024
·
6 min read
Press Releases
NeoImmuneTech Presents Promising Interim Results of CAR-T Combination with its NT-I7 Asset at ESMO 2024
September 9, 2024
·
5 min read
Press Releases
MBX Biosciences Announces Launch of Initial Public Offering
September 9, 2024
·
5 min read
Press Releases
Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival
September 9, 2024
·
12 min read
Press Releases
Kraig Biocraft Laboratories Completes New Production Center, Expands Capacity more than Eightfold
September 9, 2024
·
3 min read
Previous
9 of 17
Next